Paying user area
Try for free
UnitedHealth Group Inc. pages available for free this week:
- Balance Sheet: Liabilities and Stockholders’ Equity
- Cash Flow Statement
- Common-Size Income Statement
- Analysis of Profitability Ratios
- Enterprise Value to EBITDA (EV/EBITDA)
- Price to FCFE (P/FCFE)
- Capital Asset Pricing Model (CAPM)
- Selected Financial Data since 2005
- Operating Profit Margin since 2005
- Analysis of Revenues
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to UnitedHealth Group Inc. for $24.99.
This is a one-time payment. There is no automatic renewal.
We accept:
Current Enterprise Value (EV)
Current share price (P) | |
No. shares of common stock outstanding | |
US$ in millions | |
Common equity (market value)1 | |
Add: Preferred stock, $0.001 par value; no shares issued or outstanding (per books) | |
Add: Nonredeemable noncontrolling interests (per books) | |
Total equity | |
Add: Short-term borrowings and current maturities of long-term debt (per books) | |
Add: Long-term debt, less current maturities (per books) | |
Total equity and debt | |
Less: Cash and cash equivalents | |
Less: Short-term investments | |
Less: Assets under management | |
Enterprise value (EV) |
Based on: 10-K (reporting date: 2024-12-31).
1 Common equity (market value) = Share price × No. shares of common stock outstanding
= ×
Historical Enterprise Value (EV)
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).
1 Data adjusted for splits and stock dividends.
2 Closing price as at the filing date of UnitedHealth Group Inc. Annual Report.
3 2024 Calculation
Common equity (market value) = Share price × No. shares of common stock outstanding
= ×
- Common Equity (Market Value)
- The common equity market value showed a significant increase from 316,351 million USD in 2020 to a peak of 459,381 million USD in 2023. However, there was a notable decline in 2024 to 428,598 million USD, indicating a downward adjustment after a period of growth.
- Total Equity
- Total equity mirrored the pattern of common equity, increasing steadily from 319,188 million USD in 2020 to 465,046 million USD in 2023. In 2024, it decreased to 434,208 million USD, aligning with the drop in common equity and suggesting a reduction in overall shareholder equity.
- Total Equity and Debt
- Total combined equity and debt expanded from 362,655 million USD in 2020 to a peak of 527,583 million USD in 2023, reflecting increased leverage or capital raising activities. This was followed by a decline to 511,112 million USD in 2024, indicating a contraction in total capital employed.
- Enterprise Value (EV)
- The enterprise value rose steadily from 338,798 million USD in 2020 to 494,200 million USD in 2023, signifying growth in the company's overall valuation considering market capitalization and debt. In 2024, EV decreased slightly to 481,999 million USD, consistent with the declines observed in equity and total capital.